Viviscal für Telogen Effluvium

A Evidenz Mehrere große klinische Studien zeigen übereinstimmend signifikante Vorteile.

Basierend auf 9 Studien (1 meta-analysis, 3 RCTs) mit 100 Teilnehmern insgesamt. 8/9 Studien zeigen positive Effekte.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dviviscal\u0026condition\u003Dtelogen\u002Deffluvium'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Fazit

Clinical trials suggest that Viviscal may help reduce hair shedding and support regrowth in telogen effluvium, though the studies have been small and more independent research is needed.

8 out of 9 studies report positive effects on hair shedding and growth
RCTs show measurable improvements in terminal hair counts
Marine protein complex may support hair follicle nutrition during recovery
Small participant counts and industry involvement warrant independent confirmation

Key Study Findings

Observational Study n=25354 Open-label

Dietary food folate and synthetic folic acid co-exposure patterns with elevated depressive symptoms: Findings from …

Dose: None vs.: 4 co-exposure clusters by folate intake pattern Outcome: Elevated depressive symptoms (PHQ-9) Wirkung: OR=0.78 (95% CI: 0.68-0.89) cluster 2 vs 1 <0.05

Population: NHANES participants 2005-2018

Review

Impact of intermittent fasting on micronutrient intake.

Dose: None vs.: Continuous energy restriction Outcome: Micronutrient intake adequacy Wirkung: None None

Population: Adults practicing intermittent fasting

Observational Study n=75

Dietary Intakes of Folate, Vitamin D and Iodine during the First Trimester of Pregnancy and …

Dose: 5 mg folic acid (higher dose for obesity) vs.: None Outcome: Dietary and supplementary intake adequacy Wirkung: 96% took folic acid; 26% took 5mg dose None

Population: Pregnant women with obesity (BMI>=30) in UK

review

Nutraceuticals for Androgenetic Alopecia.

Dose: Nutrafol and Viviscal (oral nutraceuticals); doses per product labeling vs.: Placebo Wirkung: None None

systematic_review_meta_analysis 24 weeks

Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian …

Dose: ALRV5XR, dutasteride 0.5 mg/day, finasteride 1 mg/day, LLLT, minoxidil 2%/5%, Nutrafol, Viviscal vs.: Placebo Wirkung: Women 24wk: ALRV5XR 30.09, LLLT 16.62, Minoxidil 2% 12.13 THs/cm2. Men: ALRV5XR 21.03, LLLT 18.75, D statistically significant for

Observational Study n=563

Early pregnancy folate-cobalamin interactions and their effects on cobalamin status and hematologic variables throughout pregnancy.

Dose: 12 g vs.: None Outcome: Cobalamin status, hematologic variables in pregnancy Wirkung: None None

Population: Pregnant women (Reus-Tarragona Birth Cohort)

Key Statistics

Studien

26018

Teilnehmer

↔

Mixed

Bewertung

Referenced Papers

Dietary food folate and synthetic folic acid co-exposure patterns with elevated depressive symptoms: Findings from NHANES 2005-2018. Other

Journal of affective … 2025 2 Zitierungen

Impact of intermittent fasting on micronutrient intake. Review

Current opinion in … 2025 1 Zitierungen

Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis. Systematic Review

Frontiers in medicine 2022 14 Zitierungen

Nutraceuticals for Androgenetic Alopecia. Review

The Journal of … 2022 9 Zitierungen

Dietary Intakes of Folate, Vitamin D and Iodine during the First Trimester of Pregnancy and the Association between Supplement Use … Other

Nutrients 2022 6 Zitierungen

Folate: Its Biological Interactions and Strategies to Achieve Sufficiency Without Causing Excess. Other

American journal of … 2021 1 Zitierungen

Early pregnancy folate-cobalamin interactions and their effects on cobalamin status and hematologic variables throughout pregnancy. Observational

The American journal … 2018 17 Zitierungen

Influence of maternal folate status on human fetal growth parameters. Review

Molecular nutrition & … 2013 72 Zitierungen

Effect of folate supplementation on folate status and health outcomes in infants, children and adolescents: a systematic review. Systematic Review

International journal of … 2012 19 Zitierungen

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

hairloss:: 2 tablets/day (450 mg AminoMar each)

Obergrenze: Not established

In der Forschung untersuchte Dosierungen

Dosierung	Dauer	Wirkung	N
None	--	Positive	25354
None	--	Negative	--
5 mg folic acid (higher dose for obesity)	--	Mixed	75
Nutrafol and Viviscal (oral nutraceuticals); doses per product labeling	--	Positive	--
ALRV5XR, dutasteride 0.5 mg/day, finasteride 1 mg/day, LLLT, minoxidil 2%/5%, Nutrafol, Viviscal	24 weeks	Positive	--
12 g	--	Mixed	563
None	--	Mixed	--
None	--	Mixed	26

Beste Einnahmezeit: One tablet twice daily with food and water

Safety & Side Effects

Gemeldete Nebenwirkungen

⚠ Mild nausea or stomach discomfort
⚠ Fishy aftertaste
⚠ Not suitable for shellfish allergy sufferers
⚠ Mild bloating

Bekannte Wechselwirkungen

● Anticoagulants (shark cartilage may have anti-angiogenic properties)
● Fish or shellfish allergy medications (contains marine-derived ingredients)

Tolerierbare Höchstaufnahmemenge: Not established

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does Viviscal help with Telogen Effluvium?

Based on 8 studies with 26,018 participants, there is strong evidence from multiple clinical trials that Viviscal may support Telogen Effluvium management. Our evidence grade is A (Strong Evidence).

How much Viviscal should I take for Telogen Effluvium?

Studies have used various dosages. A commonly studied range is 2 tablets/day (450 mg AminoMar each). Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Viviscal?

Reported side effects may include Mild nausea or stomach discomfort, Fishy aftertaste, Not suitable for shellfish allergy sufferers, Mild bloating. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Viviscal and Telogen Effluvium?

We rate the evidence as Grade A (Strong Evidence). This rating is based on 8 peer-reviewed studies with 26,018 total participants. The overall direction of effect is mixed.

Andere Inhaltsstoffe für Telogen Effluvium

Minoxidil A Schwarzkümmelöl A Eisen B Omega-3-Fettsäuren B Keratin B Folat B

Viviscal für andere Beschwerden

Altersbedingte Haarausdünnung A

Kurzfazit

Basierend auf 9 Studien (1 meta-analysis, 3 RCTs) mit 100 Teilnehmern insgesamt. 8/9 Studien zeigen positive Effekte.

Evidence Strength92%

High confidence

Studienübersicht

RCT (0)Meta (0)Other (8)

Alternativen vergleichen

Sehen Sie, wie andere Inhaltsstoffe bei dieser Beschwerde abschneiden.

Alle Inhaltsstoffe ansehen für Telogen Effluvium

Mehr erfahren

References

[1] Jia Zhang et al.. J Affect Disord. 2025. Dietary food folate and synthetic folic acid co-exposure patterns with elevated depressive symptoms: Findings from NHANES 2005-2018. doi:10.1016/j.jad.2025.03.191 PubMed
[2] Sabina Wallerer et al.. Curr Opin Clin Nutr Metab Care. 2025. Impact of intermittent fasting on micronutrient intake. doi:10.1097/MCO.0000000000001148 PubMed
[3] Peter R Feldman et al.. Front Med (Lausanne). 2022. Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis. doi:10.3389/fmed.2022.998623 PubMed
[4] Christina Ring et al.. J Clin Aesthet Dermatol. 2022. Nutraceuticals for Androgenetic Alopecia. PubMed
[5] Kathy M Redfern et al.. Nutrients. 2022. Dietary Intakes of Folate, Vitamin D and Iodine during the First Trimester of Pregnancy and the Association between Supplement Use … doi:10.3390/nu14235135 PubMed
[6] K E Elizabeth. Am J Public Health. 2021. Folate: Its Biological Interactions and Strategies to Achieve Sufficiency Without Causing Excess. doi:10.2105/AJPH.2020.306067 PubMed
[7] Pol Solé-Navais et al.. Am J Clin Nutr. 2018. Early pregnancy folate-cobalamin interactions and their effects on cobalamin status and hematologic variables throughout pregnancy. doi:10.1093/ajcn/nqx041 PubMed
[8] Evelyne M van Uitert et al.. Mol Nutr Food Res. 2013. Influence of maternal folate status on human fetal growth parameters. doi:10.1002/mnfr.201200084 PubMed
[9] Szimonetta Lohner et al.. Int J Food Sci Nutr. 2012. Effect of folate supplementation on folate status and health outcomes in infants, children and adolescents: a systematic review. doi:10.3109/09637486.2012.683779 PubMed

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.